Is A Fall Imminent For Endo Pharmaceuticals Stock After Its Recent 58% Rise?

Is A Fall Imminent For Endo Pharmaceuticals Stock After Its Recent 58% Rise?

The stock price of Endo Pharmaceuticals has seen a stellar 58% rise over the last month, while it is up 31% in a week. There are a couple of factors that fueled this growth. First, the company recently reported its Q3 results with revenue of $772 million, well above the consensus estimate…